EU approves AbbVie's Boey for short-duration frown line treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. SPY
4. ROIV
5. ORCL
6. CRCL
7. V
8. GE
9. ASML
10. SPIR

Go back to EU approves AbbVie's Boey for short-duration frown line treatment
AbbVie (NYSE: ABBV) Delayed: 256.46 --0 (-0%)
Previous Close $256.46    52 Week High $68.12 
Open $256.46    52 Week Low $50.71 
Day High $256.46    P/E 55.63 
Day Low $256.46    EPS $4.61 
Volume 7,115